Genevieve Kanter

@profgenkanter.bsky.social

Economist and Associate Professor (University of Southern California, Public Policy) geeking out on biomed technologies, FDA, conflicts of interest, ethics in health care and government

A prolonged vacancy atop the FDA could mean delayed work on new treatments until there's greater policy clarity, USC Schaeffer's @profgenkanter.bsky.social tells Pharma Voice. “Transition delays and really, any uncertainty in leadership, are not good for the industry and not good for the public."

Why the FDA’s top spot could sit empty for months

Multiple factors could get in the way of confirming a new commissioner before the midterm elections, experts said, leaving the agency’s long-term initiatives in limbo.

pharmavoice.com

EXCLUSIVE: As the White House embraces talc + tobacco, chaos reigns at @hhsofficial.bsky.social, agency lawyers warn of legal peril - and Sec Kennedy talks UFOs w/ a billionaire. Inside the MAGA-MAHA crack-up based on 35+ sources, dozens of internal HHS docs www.rollingstone.com/politics/pol...

Are MAGA and MAHA Heading for Divorce?

Robert F. Kennedy Jr. promised ambitious plans to make Americans healthier. But insiders say as soon as he was named Health Secretary, the problems began.

rollingstone.com

Providing evidence of strategic transfer pricing by vertically integrated health care firms in response to insurer profit regulations, from Pragya Kakani, Eric Yde, Genevieve P. Kanter, Richard G. Frank, and Amelia M. Bond www.nber.org/papers/w35043

Bild

We showed a 72% drop in FDA advisory committees this past year from their 20-year average. Is this a problem? A lot of folks, incl former FDA leaders and CEOs of firms that prepped for canceled meetings think so. Link to @statnews.com article below (paywall) & free link to PDF in replies.

Lizzy Lawrence@lizzylawrence.bsky.social · 5mo ago

Despite recent controversial decisions, the FDA has stopped holding advisory committee meetings — which bring together regulators, companies, patients, and a panel of independent advisors to publicly discuss complex regulatory matters. I dug into why: www.statnews.com/2026/03/09/f...

The FDA is increasingly turning to ad hoc expert panels instead of federal advisory committees for external advice. FDA watchers generally agree these expert panels "are likely unlawful," USC Schaeffer's @profgenkanter.bsky.social tells Regulatory Focus.

Experts argue recent FDA expert panels may violate FACA requirements

The US Food and Drug Administration@s (FDA) increasing reliance on holding expert panels, rather than advisory committees, for external expert advice may violate the Federal Advisory Committee Act (FA...

raps.org

Had an in-depth conversation with Michael Gibney at PharmaVoice on politicization at the FDA and its impact on drug approvals, the pharma industry, and patients. www.pharmavoice.com/news/fda-pol... For more on FDA-industry relations, check out upcoming Health Affairs webinar on 2/17 (in replies)

Politicization runs deeper than ever at FDA, risking long-term impacts

Wide-ranging shifts at the FDA have set the stage for decisions that drag the agency through the political mud, according to an economist and public policy expert.

pharmavoice.com

In a substantial indication of public sentiment, the “Alex Pretti is an American Hero” campaign on the GoFundMe platform surpassed its goal of $20,000 quickly after organizer Keith Edwards launched it Saturday. www.theguardian.com/us-news/2026...

Online fundraiser for Alex Pretti raises nearly $400,000 day after fatal shooting

GoFundMe platform surpasses goal of $20,000 a day after federal agents killed the US citizen in Minneapolis

theguardian.com

Our latest study on physician-industry COI, out last week in The Oncologist. I have often heard the rationale that "if I'm conflicted with all the companies, then I'm unbiased." So we asked, how often DO oncologists receive payments from all competing companies? academic.oup.com/oncolo/advan...

How Often Do Oncologists Receive Industry Payments from Competing Companies?

AbstractBackground. Payments from pharmaceutical companies to oncologists can influence prescribing practices. However, some physicians believe that receiv

academic.oup.com

Something for everyone at our #ASSA2026 health care session (Sun, 1/4, 12:30-2:15 pm, Room 410). * physician altruism and industry payments * conflicts of interest in FDA advisory committees * consequences of physician disciplinary actions * immigrant enforcement and the home care industry

Bild

We are deeply saddened by the passing of Kate Ho, the John L. Weinberg Professor at Princeton and a Fellow of the Econometric Society. Kate was a brilliant IO economist and scholar whose impact on the profession will resonate for many years to come www.econometricsociety.org/publications...

In Memoriam: Kate Ho - The Econometric Society

We are deeply saddened by the passing of Kate Ho, the John L. Weinberg Professor of Economics and Business...

econometricsociety.org

NEW: FDA review staff was excluded from voting on whether to approve first priority voucher drug. Top leaders like Vinay Prasad, George Tidmarsh, and Tracy Høeg led the vote instead. Read for the full list, and expert reaction from @hollylynchez.bsky.social: www.statnews.com/2025/11/21/t...

FDA review staff was excluded from voting on whether to approve first priority voucher drug

Top officials like Vinay Prasad and George Tidmarsh voted on the drug, a major break from the FDA's typical practice.

statnews.com

The entire HR department at the CDC is gone. Everyone at the IRB, which makes sure studies are conducted ethically and rigorously, and the ethics office, which oversee conflicts of interest for CDC leaders and advisory committee members, were also let go. www.theguardian.com/us-news/2025...

‘Instability and confusion’ as CDC slashes 1,300 jobs before reinstating half

Trump administration says 700 notices were sent in error, while top CDC officer says ‘they didn’t think through what they were doing’

theguardian.com